24 May 2013
Keywords: pharmacyclics, tests, gd-tex, photosensitizer, phase, iii, start
Article | 28 September 1998
Pharmacyclics is to start pivotal Phase III multicenter trials inEurope, Canada and the USA of its Gd-Tex (gadolinium-texaphyrin) radiation sensitizer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.